2014-11-14T15:59:49-06:00 2013-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 650N BETHESDA MD 208142930 990 2013-01-01 911157127 PATH PATH 2062853500 2201 WESTLAKE AVENUE NO 200 SEATTLE WA 98121 OLIVIA POLIUS CFO 2062853500 2014-11-14 1 3019519090 2013 2015-11-30 17:44:51Z STEVE DAVIS 2201 WESTLAKE AVENUE NO 200 SEATTLE WA 98121 326602394 0 X WWW.PATH.ORG X 1981 WA SEE PART III, LINE 1. 12 12 694 0 0 0 171536869 260656932 27292 3946 2677407 2050396 739627 2433300 174981195 265144574 70398415 72704584 0 0 90685304 101626168 0 0 2924838 113262887 111371191 274346606 285701943 -99365411 -20557369 507730565 485822280 59191414 57067664 448539151 428754616 X OUR MISSION IS TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD BY ADVANCING TECHNOLOGIES, STRENGTHENING SYSTEMS, AND ENCOURAGING HEALTHY BEHAVIORS. (CONTINUED ON SCHEDULE O) PATH IS THE LEADER IN GLOBAL HEALTH INNOVATION. AN INTERNATIONAL NONPROFIT ORGANIZATION, WE SAVE LIVES AND IMPROVE HEALTH, ESPECIALLY AMONG WOMEN AND CHILDREN. WE ACCELERATE INNOVATION ACROSS FIVE PLATFORMS-VACCINES, DRUGS, DIAGNOSTICS, DEVICES, AND SYSTEM AND SERVICE INNOVATIONS-THAT HARNESS OUR ENTREPRENEURIAL INSIGHT, SCIENTIFIC AND PUBLIC HEALTH EXPERTISE, AND PASSION FOR HEALTH EQUITY. BY MOBILIZING PARTNERS AROUND THE WORLD, WE TAKE INNOVATION TO SCALE, WORKING ALONGSIDE COUNTRIES PRIMARILY IN AFRICA AND ASIA TO TACKLE THEIR GREATEST HEALTH NEEDS. TOGETHER, WE DELIVER MEASURABLE RESULTS THAT DISRUPT THE CYCLE OF POOR HEALTH. 0 0 105218480 37563343 1762 PRODUCT DEVELOPMENT: PATH DEVELOPS AND INTRODUCES APPROPRIATE, AFFORDABLE TECHNOLOGIES TO ADDRESS URGENT HEALTH CHALLENGES, PARTICULARLY IN LOW-RESOURCE SETTINGS. THESE TECHNOLOGIES INCLUDE VACCINES, DRUGS, DIAGNOSTICS, DEVICES, AND DIGITAL HEALTH SOLUTIONS. DESIGNED WITH INPUT FROM USERS AND RECIPIENTS, OUR LOW-COST, EVIDENCE-BASED PRODUCTS ARE TRANSFORMING HEALTH WORLDWIDE. PATH ACCELERATES THE DEVELOPMENT AND DELIVERY OF RELIABLE, LOW-COST VACCINES AGAINST LIFE-THREATENING DISEASES. OUR PORTFOLIO INCLUDES VACCINES FOR DIARRHEAL DISEASE, INFLUENZA, JAPANESE ENCEPHALITIS, MALARIA, MENINGITIS, PNEUMOCOCCAL DISEASE, POLIO, AND MORE, AS WELL AS INNOVATIVE DELIVERY STRATEGIES TO ENSURE VACCINES REACH THE SETTINGS WHERE THEY ARE NEEDED MOST. IN 2013, WE SAW SIGNIFICANT SUCCESS IN OUR EFFORTS TO BRING VACCINES TO MORE COMMUNITIES, ADVANCE NEW VACCINE CANDIDATES, AND STRENGTHEN SUPPLY CHAINS AND SYSTEMS.THE WORLD HEALTH ORGANIZATION (WHO) GRANTED ITS STAMP OF APPROVAL, CALLED PREQUALIFICATION, TO A PATH-ADVANCED VACCINE TO FIGHT JAPANESE ENCEPHALITIS. PATH HAD IDENTIFIED THE VACCINE, HELPED THE CHINESE MANUFACTURER MEET REGULATORY STANDARDS, SECURED AN AFFORDABLE PUBLIC-SECTOR PRICE, AND PREPARED COUNTRIES TO INTRODUCE IT. WE ARE WORKING WITH PARTNERS TO ROLL OUT THE VACCINE ACROSS ASIA.IN 2013, ANOTHER 50 MILLION AFRICANS WERE VACCINATED WITH THE MENAFRIVAC VACCINE, WHICH WAS DEVELOPED BY PATH, WHO, AND SERUM INSTITUTE OF INDIA LTD. TO PROTECT AGAINST DEADLY MENINGITIS A. NO CASES OF MENINGITIS A HAVE BEEN REPORTED AMONG THE 153 MILLION AFRICANS VACCINATED SINCE 2010. A STUDY REPORTED IN 2013 FOUND THAT THE VACCINE IS HAVING A DRAMATIC IMPACT ON MENINGITIS: THE INCIDENCE OF ALL FORMS OF THE DISEASE DROPPED BY 94 PERCENT FOLLOWING A MASS IMMUNIZATION CAMPAIGN IN CHAD.PATH ALSO HELPED TO ADVANCE AN AFFORDABLE NEW VACCINE AGAINST THE MOST LETHAL FORM OF DIARRHEA. ROTAVAC REDUCES SEVERE ROTAVIRUS DIARRHEA BY 56 PERCENT IN THE FIRST YEAR OF LIFE AND AT A FRACTION OF THE PRICE OF CURRENTLY AVAILABLE VACCINES. IT HAS NOW BEEN LICENSED BY THE GOVERNMENT OF INDIA. IN ADDITION, PATH HELPED INTRODUCE CURRENTLY AVAILABLE ROTAVIRUS VACCINES TO SEVEN COUNTRIES IN 2013 THROUGH ADVOCACY AND COMMUNICATIONS SUPPORT.PATH CONTINUED TO COLLABORATE WITH GLAXOSMITHKLINE AND OTHERS IN THE FINAL PHASE OF CLINICAL TRIALS OF A VACCINE SHOWN TO HELP PROTECT YOUNG CHILDREN AGAINST THE DEADLIEST MALARIA PARASITE. A PHASE 3 TRIAL FOUND THAT THE VACCINE CANDIDATE, RTS,S, CONTINUED TO PROVIDE MODEST PROTECTION FROM CLINICAL MALARIA FOR INFANTS AND TODDLERS UP TO 18 MONTHS AFTER VACCINATION. PATH'S DRUG WORK ALSO ACHIEVED GAINS IN 2013. PATH DEVELOPS AND INTRODUCES AFFORDABLE DRUGS FOR DISEASES THAT DISPROPORTIONATELY AFFECT PEOPLE IN LOW-INCOME COUNTRIES, INCLUDING DRUGS TO TREAT OR PREVENT DIARRHEA, HIV, MALARIA, AND NEWBORN INFECTIONS. THANKS TO A GLOBAL PARTNERSHIP CONVENED BY PATH THAT DEVELOPED A SEMISYNTHETIC FORM OF ARTEMISININ, MILLIONS MORE PEOPLE WILL BENEFIT FROM THE GOLD-STANDARD MALARIA TREATMENT. THE LAUNCH OF INDUSTRIAL-SCALE PRODUCTION OF SEMISYNTHETIC ARTEMISININ AND WHO PREQUALIFICATION IN 2013 CAPPED A NINE-YEAR EFFORT. UP TO 60 METRIC TONS CAN BE PRODUCED EACH YEAR, WHICH IS ENOUGH TO MEET ONE-THIRD OF THE TOTAL GLOBAL NEED.PATH SAW RESULTS IN OUR INTERNATIONAL EFFORT TO ADAPT A PROVEN ANTISEPTIC, CALLED CHLORHEXIDINE, INTO A NEW FORMULATION FOR USE ON NEWLY CUT UMBILICAL CORDS. AN ESTIMATED 300,000 BABIES COULD BE SAVED EACH YEAR AT A COST OF LESS THAN 50 CENTS A DOSE. IN 2013, WHO ENDORSED THE PRODUCT. IMPLEMENTATION IS UNDER WAY IN 16 COUNTRIES. PATH CONTINUED ITS WORK TO DEVELOP AND INTRODUCE FAST, ACCURATE DIAGNOSTIC TECHNOLOGIES TO DETECT AND TRACK SUCH DISEASES AS CERVICAL CANCER, DIABETES, HIV, MALARIA, NEGLECTED TROPICAL DISEASES, AND TUBERCULOSIS (TB).WE DEVELOPED A NEW DIAGNOSTIC TOOL TO ACCELERATE EFFORTS TO ELIMINATE RIVER BLINDNESS, OR ONCHOCERCIASIS, A LEADING CAUSE OF PREVENTABLE BLINDNESS IN AFRICA. PATH'S DIAGNOSTIC IS THE ONLY ANTIBODY TEST FOR THE DETECTION OF RIVER BLINDNESS TAILORED FOR USE IN THE RURAL AND REMOTE SETTINGS WHERE PEOPLE ARE MOST AFFECTED. IN 2013, WE TRANSFERRED THE TECHNOLOGY TO A SOUTH KOREAN MANUFACTURER, AND WE ARE WORKING TOGETHER TO BRING THE TEST TO MARKET.PATH ALSO WORKS WITH THE PEOPLE WE SERVE TO DEVELOP, ADAPT, AND INTRODUCE HEALTH DEVICES THAT IMPROVE MATERNAL, REPRODUCTIVE, AND NEWBORN HEALTH; NUTRITION; AND WATER AND SANITATION.A KEY 2013 FOCUS WAS INCREASING CONTRACEPTIVE OPTIONS FOR THE 222 MILLION WOMEN WORLDWIDE WHO WANT TO AVOID PREGNANCY BUT ARE NOT USING MODERN CONTRACEPTION. THE SILCS DIAPHRAGM-A ONE-SIZE-FITS-MOST CONTRACEPTIVE DEVICE-WENT ON SALE IN SIX EUROPEAN COUNTRIES IN 2013. IT IS THE FIRST NEW CERVICAL BARRIER METHOD TO REACH THE MARKET IN MORE THAN A DECADE. PATH IS NOW ASSESSING HOW TO INTRODUCE THE DEVICE IN LOW-RESOURCE SETTINGS, INCLUDING INDIA, SOUTH AFRICA, AND UGANDA.PATH AND OUR PARTNERS ALSO DESIGNED THE WOMAN'S CONDOM, WHICH PROTECTS WOMEN FROM BOTH PREGNANCY AND SEXUALLY TRANSMITTED INFECTIONS, INCLUDING HIV. THE WOMAN'S CONDOM WAS APPROVED FOR SALE IN SOUTH AFRICA IN 2013. WE BUILT DEMAND FOR FEMALE CONDOMS OVERALL THROUGH CAMPAIGNS SUCH AS AN INTERNATIONAL FILM CONTEST, WITH WINNING FILMS SCREENED IN MORE THAN TEN COUNTRIES.FINALLY, OUR DIGITAL HEALTH SOLUTIONS GROUP (FORMERLY HEALTH MANAGEMENT INFORMATION SYSTEMS) PROVIDED INFORMATION AND COMMUNICATION TECHNOLOGY PRODUCTS AND SERVICES THAT ADDRESS THE SPECIFIC HEALTH NEEDS OF PROGRAMS AND COUNTRIES. AN EXAMPLE OF THIS WORK IS THE BETTER IMMUNIZATION DATA (BID) INITIATIVE, WHICH SUPPORTS AFRICAN COUNTRIES INTERESTED IN IMPROVING THEIR HEALTH INFORMATION SYSTEM PRODUCTS, POLICIES, AND PRACTICES AROUND DATA QUALITY, COLLECTION, AND USE IN ORDER TO ENABLE EVIDENCE-BASED DECISION-MAKING. 74487133 22727162 INTERNATIONAL DEVELOPMENT: PATH'S ON-THE-GROUND EXPERIENCE ALLOWS US TO APPLY TAILOR-MADE SOLUTIONS TO URGENT HEALTH NEEDS IN THE COMMUNITIES WE SERVE. PATH COLLABORATES WITH COUNTRY PARTNERS TO IMPLEMENT AN ARRAY OF INNOVATIONS THAT STRENGTHEN HEALTH SYSTEMS, ENCOURAGE HEALTHIER BEHAVIORS, AND INCREASE ACCESS TO AFFORDABLE SOLUTIONS. IN 2013, OUR INTERNATIONAL DEVELOPMENT PORTFOLIO SUPPORTED OFFICES IN 22 COUNTRIES. THIS WORK RANGED FROM SMALL-SCALE PILOTS OF INNOVATIVE SOLUTIONS FOR LOCAL PROBLEMS TO THE LARGEST INTEGRATED HEALTH PROJECT IN EAST AFRICA.THROUGH THE PATH-LED APHIAPLUS WESTERN KENYA PROJECT, WE ARE IMPLEMENTING INTEGRATED STRATEGIES TO TACKLE THE REGION'S GREATEST HEALTH THREATS. IN 2013, WE TRAINED 5,600 COMMUNITY HEALTH WORKERS TO PROVIDE HEALTH EDUCATION AND SUPPORT, ESTABLISHED A COMMUNITY-BASED MOTORCYCLE AMBULANCE SERVICE FOR WOMEN IN LABOR, AND DEVISED A COMPREHENSIVE MALARIA STRATEGY FOR THE REGION. IN ALL, WE REACHED MORE THAN 3.7 MILLION KENYANS IN 2013 WITH INTEGRATED SERVICES FOR HIV/AIDS, MALARIA, MATERNAL AND CHILD HEALTH, AND TB. IN VIETNAM, WE ARE WORKING WITH LOCAL VACCINE MANUFACTURERS TO PRODUCE AND TEST SEASONAL AND AVIAN INFLUENZA VACCINES AS AN IMPORTANT STEP TOWARD INCREASING LOCAL AND REGIONAL VACCINE SUPPLIES TO RESPOND TO OUTBREAKS. WE ALSO IMPLEMENTED AN INNOVATIVE MOBILE HEALTH APPLICATION TO INCREASE TB TREATMENT ADHERENCE. THE SOFTWARE LINKS TO THE NATIONAL TB TREATMENT MANAGEMENT DATABASE AND SENDS SMS TEXTS TO PATIENTS, REMINDING THEM TO TAKE THEIR MEDICINE AND ATTEND HEALTH CHECKUPS. THE APPLICATION INCREASED TB TREATMENT ADHERENCE FROM 91 TO 98 PERCENT.IN INDIA, PATH IS SUPPORTING IMMUNIZATION CAMPAIGNS AND OTHER MEASURES TO CONTROL JAPANESE ENCEPHALITIS AND ACUTE ENCEPHALITIS SYNDROME. IN THE STATE OF BIHAR, 13.3 MILLION CHILDREN WERE IMMUNIZED AGAINST JAPANESE ENCEPHALITIS. THE STATE OF UTTAR PRADESH ESTABLISHED 100 ENCEPHALITIS TREATMENT CENTERS FOR CLINICAL MANAGEMENT OF THE TWO DISEASES TO PREVENT CHILDREN FROM DYING. FINALLY, AS PART OF PATH'S COMPREHENSIVE STRATEGY TO ELIMINATE MALARIA IN AFRICA, WE WORK WITH NATIONAL MALARIA PROGRAMS IN A NUMBER OF COUNTRIES TO EXPAND COMPREHENSIVE TESTING AND TREATMENT, IMPROVE DATA COLLECTION, AND INCREASE SURVEILLANCE. FOR EXAMPLE, IN SENEGAL, PATH TEAMED UP WITH EMPLOYERS, PHARMACIES, GOVERNMENT AGENCIES, AND OTHERS TO CREATE ZERO-MALARIA-TRANSMISSION ZONES BY PILOTING INNOVATIVE USES OF DRUGS AND DIAGNOSTICS AND BY IMPROVING THE TIMELINESS AND QUALITY OF DATA REPORTING. IN 2013, WE EXPANDED THE APPROACH TO THREE NEW DISTRICTS. WORKING WITH A NETWORK OF PARTNERS IN THE COUNTRY, WE HAVE CONTRIBUTED TO A 62 PERCENT DROP IN MALARIA DEATHS SINCE 2006. 50803374 9947242 1361 PUBLIC HEALTH IMPACT: PATH WORKS WITH COMMUNITIES AROUND THE WORLD TO DEVELOP NEW SYSTEM AND SERVICE INNOVATIONS AND INTRODUCE PROVEN STRATEGIES TO IMPACT HEALTH OUTCOMES. WE WORK WITH GOVERNMENTS, COMMUNITIES, AND CIVIL-SOCIETY GROUPS TO ENSURE SOLUTIONS ARE APPROPRIATE, AVAILABLE, AND AFFORDABLE TO THOSE WHO NEED THEM. PATH'S PUBLIC HEALTH IMPACT PORTFOLIO DEVELOPS, INTRODUCES, AND SUPPORTS INNOVATIONS FOR THREE CRITICAL HEALTH AREAS: HIV/AIDS AND TB, REPRODUCTIVE HEALTH, AND MATERNAL AND CHILD HEALTH AND NUTRITION.TO REDUCE THE BURDEN OF HIV/AIDS AND TB, PATH FOCUSED ON STRENGTHENING DIAGNOSIS, CARE, AND TREATMENT SERVICES; STEPPING UP PREVENTION EFFORTS, INCLUDING PREVENTING MOTHER-TO-CHILD TRANSMISSION OF HIV; AND BUILDING THE FOUNDATIONS THAT LOCAL AND NATIONAL HEALTH SYSTEMS NEED TO COMBAT BOTH DISEASES. THROUGH A RANGE OF PROJECTS, WE REACHED HUNDREDS OF THOUSANDS OF PEOPLE IN 2013. FOR EXAMPLE, IN THE DEMOCRATIC REPUBLIC OF THE CONGO, THE PATH-LED PROVIC PROJECT REACHED MORE THAN 325,000 PEOPLE WITH HIV PREVENTION, CARE, AND TREATMENT SERVICES IN 2013. WITH OUR PARTNERS, WE LAUNCHED A CLOUD-BASED MONITORING AND EVALUATION DATABASE THAT ANALYZES AND SHARES DATA ACROSS HIV "HOTSPOTS." WHEN THE DATA SHOWED THAT MOTHERS IN A PROGRAM TO PREVENT MOTHER-TO-CHILD HIV TRANSMISSION WERE NOT FOLLOWING UP WITH TREATMENT, WE LAUNCHED A MENTORING PROGRAM THAT DOUBLED THE NUMBER OF WOMEN ON TREATMENT. THROUGH A PROGRAM CALLED ARISE-ENHANCING HIV PREVENTION FOR AT-RISK POPULATIONS-PATH COLLABORATED WITH DIVERSE PARTNERS IN INDIA AND FOUR AFRICAN COUNTRIES TO SCALE UP INNOVATIVE HIV PREVENTION STRATEGIES TARGETED AT VULNERABLE COMMUNITIES-INJECTING DRUG USERS, FEMALE SEX WORKERS, SERODISCORDANT COUPLES, MEN WHO HAVE SEX WITH MEN, AND HIV-POSITIVE WOMEN AND BABIES.PATH ALSO WORKED WITH DIVERSE PARTNERS TO INTEGRATE DETECTION AND CARE FOR TB INTO HEALTH SERVICES FOR CHILD HEALTH, DIABETES, HIV, AND OTHER CONDITIONS. FOR EXAMPLE, WE IMPLEMENTED TB-HIV COLLABORATIVE ACTIVITIES IN 1,125 FACILITIES IN TANZANIA. NEARLY 20,000 PEOPLE DIAGNOSED WITH TB WERE REFERRED FOR HIV TESTING; 22 PERCENT WERE FOUND TO BE HIV POSITIVE AND REGISTERED FOR HIV CARE. THE RATES OF HIV-POSITIVE PATIENTS STARTING TREATMENT INCREASED DRAMATICALLY, FROM 34 PERCENT IN 2012 TO MORE THAN 67 PERCENT IN 2013.PATH'S REPRODUCTIVE HEALTH PROGRAM CONTINUED ITS WORK TO STRENGTHEN ACCESS TO FAMILY PLANNING, IMPROVE SCREENING AND TREATMENT FOR CERVICAL AND BREAST CANCERS, PREVENT SEXUALLY TRANSMITTED INFECTIONS, ADVOCATE FOR SERVICES AND SUPPLIES, INTRODUCE CONTRACEPTIVE TECHNOLOGIES, AND ENCOURAGE HEALTHY BEHAVIORS. ONE OF OUR KEY EFFORTS IN 2013 WAS PAVING THE WAY FOR A NEW FORM OF A POPULAR INJECTABLE CONTRACEPTIVE. THE PRODUCT, SAYANA PRESS, WAS ADAPTED FOR DELIVERY IN THE UNIJECT INJECTION SYSTEM, DEVELOPED BY PATH AND TRADEMARKED BY BD. THE MEDICATION IS CONTAINED IN A SMALL PREFILLED SYRINGE THAT IS EASY TO TRANSPORT AND USE, EXPANDING THE CADRE OF HEALTH WORKERS WHO CAN PROVIDE INJECTIONS. PATH COORDINATED PLANNING AMONG GLOBAL AND COUNTRY PARTNERS IN PREPARATION FOR INTRODUCTION OF SAYANA PRESS IN FOUR AFRICAN COUNTRIES IN 2014. PATH ALSO ENHANCED THE SUSTAINABILITY OF FAMILY PLANNING PROGRAMS IN LOW-AND MIDDLE-INCOME COUNTRIES BY WORKING TO LINK PUBLIC- AND PRIVATE-SECTORS IN COMPRHENSIVE, TOTAL MARKET APPROACHES TO MEET CONTRACEPTIVE NEEDS.PATH ALSO SERVED AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF 300 PUBLIC, PRIVATE, AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO SUPPLIES, SERVICES, AND OPTIONS FOR PREVENTING UNINTENDED PREGNANCIES AND SEXUALLY TRANSMITTED INFECTIONS.AS PART OF OUR NONCOMMUNICABLE DISEASES PROGRAM, PATH WORKS TO IMPROVE DETECTION AND TREATMENT OF CERVICAL AND BREAST CANCERS. IN 2013, WE REFINED AND EXPANDED A PILOT PROJECT IN PERU THAT IS INCREASING WOMEN'S ACCESS TO EARLY DETECTION AND TREATMENT OF BREAST CANCER, ADDING A PATIENT NAVIGATION PROGRAM AND CURRICULUM FOR A BIOPSY TECHNIQUE CALLED FINE-NEEDLE ASPIRATION. FINALLY, OUR PUBLIC HEALTH IMPACT PORTFOLIO IMPROVED THE HEALTH OF WOMEN AND CHILDREN THROUGH EVIDENCE-BASED APPROACHES THAT TACKLE THE LEADING CAUSES OF MATERNAL AND CHILD DEATH IN LOW-RESOURCE SETTINGS. POSTPARTUM HEMORRHAGE, OR EXCESSIVE BLEEDING AFTER CHILDBIRTH, IS THE LEADING CAUSE OF MATERNAL DEATH WORLDWIDE. A CLINICAL TRIAL COMPLETED BY PATH'S OXYTOCIN INITIATIVE IN 2013 FOUND THAT USE OF OXYTOCIN IN THE UNIJECT INJECTION SYSTEM BY COMMUNITY HEALTH WORKERS IN GHANA REDUCED THE RISK OF POSTPARTUM HEMORRHAGE DURING HOME-BASED BIRTHS. PATH CO-FACILITATED THE DRAFTING OF A NATIONAL STRATEGY TO ADDRESS POSTPARTUM HEMORRHAGE USING RESULTS AND RECOMMENDATIONS FROM THE CLINICAL TRIAL.IN SOUTH AFRICA AND MOZAMBIQUE, WE CONTINUED TO EXPAND OUR TRAINING AND MENTORING OF MATERNAL AND CHILD HEALTH PROVIDERS THROUGH THE WINDOW OF OPPORTUNITY PROJECT, WHICH SERVES A POPULATION OF APPROXIMATELY 4 MILLION.TO REDUCE NEONATAL MORTALITY AND IMPROVE NUTRITION, PATH IS WORKING TO STRENGTHEN HUMAN MILK BANKING TO ENSURE INFANTS HAVE ACCESS TO DONOR BREAST MILK WHEN THEIR MOTHERS' MILK IS UNAVAILABLE. IN 2013, WE LAUNCHED "STRENGTHENING HUMAN MILK BANKING: A GLOBAL IMPLEMENTATION FRAMEWORK" TO PROVIDE GUIDANCE ON ESTABLISHING SAFE SYSTEMS. WE ALSO COLLABORATED ON THE EVALUATION OF A LOW-COST SYSTEM THAT USES MOBILE PHONES TO MANAGE THE PASTEURIZATION OF DONATED BREAST MILK.THROUGH THE MAXIMISING THE QUALITY OF SCALING UP NUTRITION PROJECT, A PATH-LED CONSORTIUM WORKED WITH OVER 20 COUNTRIES TO ADDRESS UNDERNUTRITION BY BUILDING CAPACITY, GENERATING EVIDENCE, FACILITATING HIGH-QUALITY PROGRAM DESIGN, AND TESTING INNOVATIVE NUTRITION SOLUTIONS. WE ALSO HELPED DEVELOP STRATEGIC DISTRIBUTION MODELS TO INCREASE ACCESS TO RICE FORTIFIED WITH VITAMINS AND MINERALS USING THE ULTRA RICE FORTIFICATION TECHNOLOGY, ADVANCED BY PATH AND TRADEMARKED BY BON DENTE INTERNATIONAL, INC. FORTIFIED GRAINS ARE BEING INTEGRATED INTO LARGE-SCALE FOOD ASSISTANCE PROGRAMS IN BURUNDI AND CAMBODIA, RETAIL CHANNELS IN BRAZIL, AND SMALL-SCALE DISTRIBUTION CHANNELS IN MALI. IN INDIA, WE HELPED ESTABLISH PRODUCTION OF FORTIFIED GRAINS FOR A WORLD FOOD PROGRAMME PILOT PROJECT THAT REACHED 100,000 CHILDREN. 7996340 2466837 823 OTHER PROGRAM SERVICES: PATH'S ADVOCACY AND PUBLIC POLICY PROGRAM WORKS IN THE UNITED STATES, THE INTERNATIONAL ARENA, AND COUNTRIES AND COMMUNITIES AROUND THE WORLD TO HELP POLICYMAKERS UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH EFFORTS. IN 2013, PATH'S ADVOCACY HELPED TO EXPAND THE MANDATE OF ONE OF THE WORLD'S LARGEST PUBLIC-PRIVATE PARTNERSHIPS FOR RESEARCH AND DEVELOPMENT OF NEW HEALTH TECHNOLOGIES TO FIGHT INFECTIOUS DISEASES. AS A RESULT OF OUR WORK, THE SCOPE OF THE EUROPEAN AND DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP NOW INCLUDES ACCELERATING CLINICAL TESTING OF TOOLS TO CONTROL NEGLECTED DISEASES LINKED TO POVERTY. OUR IN-COUNTRY SUPPORT ALSO HAD SUCCESS IN ADVANCING HEALTH POLICIES WITH THE POTENTIAL TO IMPROVE THE HEALTH OF WOMEN AND CHILDREN. FOR EXAMPLE, IN ZAMBIA, TWO MAJOR POLICIES TO EXPAND AND IMPROVE NEWBORN HEALTH CARE WERE APPROVED BY THE COUNTRY'S MINISTRY OF HEALTH AS A RESULT OF OUR ADVOCACY AND POLICY DEVELOPMENT SUPPORT TO COUNTRY HEALTH ADVISORS. ZAMBIA IS A COUNTRY WITH HIGH INFANT MORTALITY AND PREVIOUSLY HAD FEW POLICIES TO REDUCE THE PREVENTABLE DEATHS OF NEWBORNS.PATH HAS A STRATEGY TO INTEGRATE, COORDINATE, AND STRATEGICALLY LEVERAGE PATH'S PROGRAMS, INTERVENTIONS, AND STAFF EXPERTISE TO MAXIMIZE IMPACT AND VALUE FOR MONEY. A KEY PART OF THIS WORK IS IMPLEMENTING CAREFULLY TARGETED, MULTIYEAR INITIATIVES CALLED IMPACT INITIATIVES. THROUGH THE IMPACT INITIATIVES, CROSS-PROGRAM TEAMS IDENTIFY HIGH-PRIORITY AREAS FOR IMPROVEMENT, SET INSTITUTIONAL GOALS, AND THEN MOBILIZE RESOURCES TO ACHIEVE THEM. THE 2013 IMPACT INITIATIVE INCLUDE MATERNAL AND NEONATAL HEALTH TECHNOLOGIES, DIARRHEAL DISEASE AND PNEUMONIA, MALARIA, AND FAMILY PLANNING. 7996340 2466837 823 238505327 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 X 230 0 1 694 1 0 1 BE CB CH CG ET FR GH IN MZ BM NU PE SZ TZ TH UG KE UP VM ZA SG SF 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AZ CA CT FL IL MA MD NJ NY NC OH OR PA TX VA VT WA X X OLIVIA POLIUS CHIEF FINANCIAL OFFICER 2062853500 2201 WESTLAKE AVE SUITE 200 SEATTLE WA 98121 GEORGE GOTSADZE BOARD CHAIR 2.00 0.00 X X 0 0 0 DEAN ALLEN BOARD VICE CHAIR & TREASURER 2.00 0.00 X X 0 0 0 EIVOR HALKJAER BOARD SECRETARY 2.00 0.00 X X 0 0 0 PHYLLIS CAMPBELL DIRECTOR 2.00 0.00 X 0 0 0 DAVID KING DIRECTOR 2.00 0.00 X 0 0 0 JO ADDY DIRECTOR 2.00 0.00 X 0 0 0 ALEX CHIKA EZEH DIRECTOR 2.00 0.00 X 0 0 0 KEVIN REILLY DIRECTOR 2.00 0.00 X 0 0 0 KOFI AMEGASHIE DIRECTOR 2.00 0.00 X 0 0 0 VINCENT MCGEE DIRECTOR 2.00 0.00 X 0 0 0 RAJENDRA VATTIUTI DIRECTOR 2.00 0.00 X 0 0 0 FELIX OLALE DIRECTOR 2.00 0.00 X 0 0 0 STEVEN B DAVIS PRESIDENT AND CEO 38.00 2.00 X 481239 0 41628 ERIC G WALKER VP, CORPORATE SVC. (UNTIL 10/2/2013) 38.00 2.00 X 352054 0 34611 OLIVIA POLIUS CFO (BEGAN 6/10/2013) 38.00 2.00 X 99511 0 6116 MICHAEL B KOLLINS COO (BEGAN 5/31/2013) 40.00 0.00 X 140267 0 12850 DAVID C KASLOW VP, PRODUCT DEV. (BEGAN 10/1/2013) 37.00 3.00 X 322463 0 39519 AYORINDE ARNOLD AJAYI VP, INTERNATIONAL DEVELOPMENT 40.00 0.00 X 256904 0 34738 SARAH C TEMPLE VP, EXTERNAL RELATIONS 40.00 0.00 X 226095 0 35911 DAN LASTER GENERAL COUNSEL 38.00 2.00 X 225160 0 35498 JACQUELINE D SHERRIS VP, PUBLIC HEALTH IMPACT 37.00 3.00 X 208881 0 27440 KATHRYN A O'DRISCOLL CHIEF HUMAN RESOURCES OFFICER 40.00 0.00 X 206793 0 35630 AMIE E BATSON CHIEF STRATEGY OFF. (BEGAN 4/8/13) 39.00 1.00 X 193128 0 10579 JOHN W BOSLEGO DIRECTOR, VACCINE DEV. GLOBAL PROG. 40.00 0.00 X 319488 0 39990 PAWANA WIENRAWEE DIRECTOR, THAILAND PROGRAMS 40.00 0.00 X 284354 0 24004 PONNI SUBBIAH DIRECTOR, DRUG DEVELOPMENT 40.00 0.00 X 277216 0 31334 RIKKA E TRANGSRUD COUNTRY PROGRAM LEADER, KENYA 40.00 0.00 X 275656 0 28983 TRAD M HATTON CHIEF OF PARTY, INTEGRATED HIV/AIDS 40.00 0.00 X 265397 0 24096 CARLOS CLINTON CAMPBELL DIRECTOR, MALARIA CONTROL PROGRAM 40.00 0.00 X 254674 0 27863 ANURAG PRABHAKAR MAIRAL DIRECTOR, TECHNOLOGY SOLUTIONS 40.00 0.00 X 254450 0 25042 ASHLEY BIRKETT DIRECTOR, RESEARCH AND DEVELOPMENT 40.00 0.00 X 245265 0 37215 RAMONA ANNE BYRKIT COUNTRY PROGRAM LEADER, VIETNAM 40.00 0.00 X 242849 0 29422 KATHLEEN M NEUZIL GLOBAL PROGRAM LEADER, VAD 40.00 0.00 X 234320 0 34920 CATHARINE HOWARD TAYLOR GLOBAL PROGRAM LEADER, MCHN 40.00 0.00 X 210119 0 32903 JANE E HUTCHINGS DIRECTOR, REPRODUCTIVE HEALTH 40.00 0.00 X 198328 0 33996 RACHEL WILSON SENIOR DIRECTOR, POLICY & ADVOCACY 40.00 0.00 X 190242 0 32157 JOHN SKIBIAK DIRECTOR, RHSC 40.00 0.00 X 267549 0 33103 JEAN A NTUMBA BIDUAYA FIN. & ADMIN. SPECIALIST, HIV & TB 40.00 0.00 X 249682 0 18900 DUNCAN OWENS EARLE PROG. DIR., MALARIA CONTROL & EVAL. 40.00 0.00 X 243590 0 30851 BONIFACE MUTOMBO WA MUTOMBO SENIOR PROGRAM OFFICER 40.00 0.00 X 240288 0 24848 GEORGE A ROBERTSON SENIOR TECHNICAL ADVISOR 40.00 0.00 X 228411 0 38353 7194373 0 862500 211 0 1 0 SLALOM LLC 821 2ND AVE STE 1900 SEATTLE WA 98124 GENERAL CONTRACTOR 1231957 WIDENET CONSULTING GROUP LLC 11400 SE 6TH ST BELLEVUE WA 98004 CONSULTING 965834 CURTIS CONSULTING GROUP INC 385 FRONT ST N ISAQUAH WA 98027 GENERAL CONTRACTOR 751650 TERRA SERVICES INC PO BOX 202056 DALLAS TX 75320 GENERAL CONTRACTOR 438076 NORTHERN TRUST 50 S LASALLE ST CHICAGO IL 60675 ASSET MANAGEMENT 342663 15 18468421 134832852 107355659 107486 260656932 HONORARIUM 900099 2848 2848 SALES 900099 961 961 CONSULTANCIES 541900 137 137 3946 1577422 1577422 409 409 61680200 250594 61201314 256506 478886 -5912 472974 472974 GAIN-FOREIGN EXCH. 900099 2101509 2101509 REIMBURSEMENTS 900099 250095 250095 OTHER 900099 81287 81287 2432891 265144574 3946 0 4483696 33377700 33377700 39326884 39326884 6698256 3994374 2650930 52952 72296991 43261725 28148617 886649 7030592 7030592 9663814 694132 8969682 5936515 412245 5524270 516660 118915 397745 555785 154116 401669 27000 12000 15000 312703 312703 12598323 7100364 5317655 180304 218752 123356 87605 7791 6175984 4877457 1243109 55418 1043538 371097 623542 48899 147271 144906 2365 9782260 987844 8792311 2105 21685946 19636132 1994331 55483 8555307 7950654 439240 165413 93052 93052 2453801 179178 2274623 438243 118674 319569 SUBCONTRACTS 34183269 33094547 783874 304848 EQUIP RENT & MAINT 4851665 3607546 1228445 15674 FACILITIES ALLOC 0 9454348 -9751809 297461 LEAVE & BENS ALLOC 0 22902806 -23376054 473248 7731632 6604327 748712 378593 285701943 238505327 44271778 2924838 5456357 13397133 7755742 40026863 267202359 254302858 7835110 7771974 2621049 2850259 34181385 15603671 20359258 18577714 196097539 148068288 403151 223973 0 603218 507730565 485822280 53959115 52731771 5232299 4335893 59191414 57067664 X 20660464 21836456 424503642 403540565 3375045 3377595 448539151 428754616 507730565 485822280 -20557369 772834 0 X 0 1 X 1 1 1 X 257511086 152434405 240628741 171536869 260656932 1082768033 257511086 152434405 240628741 171536869 260656932 1082768033 300921187 781846846 5825631 4380066 2797154 2295453 1577831 16876135 524296 1557958 502596 730742 2432891 5748483 1105392651 228313 0.70730 0.61400 X SCHEDULE A, PART II, SECTION B, LINE 10 - OTHER INCOME: REIMBURSEMENTS BY THIRD PARTIES OF EXPENSES INCURRED BY PATH AND OTHER MISCELLANEOUS REVENUE: $331,382 AND GAIN ON FOREIGN EXCHANGE OF $2,101,509. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3098 103582 106680 285595263 285701943 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 219409 197270 193545 106680 716904 250000 250000 250000 250000 1000000 1500000 6398 3098 9496 7806786 2550 1503301 295643 9016994 6868767 5392 932627 7806786 6671532 2700 194535 6868767 5943911 1790 725831 6671532 4752059 2039 1189813 5943911 0.36000 0.37000 0.27000 0 0 20110981 6385895 13725086 10580624 7809973 2770651 3489780 1407803 2081977 18577714 PART V, LINE 4: PATH UTILIZES THE INVESTED INTEREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY. 1 CENTRAL AMERICA AND THE CARIBBEAN 1 1 MANAGEMENT & GENERAL 54724 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES INTERNATIONAL DEVELOPMENT 38698 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 166479 EAST ASIA AND THE PACIFIC 5 57 MANAGEMENT & GENERAL 2073133 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES PRODUCT DEVELOPMENT 1074399 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES INTERNATIONAL DEVELOPMENT 2838159 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 141542 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES OTHER 146778 EAST ASIA AND THE PACIFIC 0 0 FUNDRAISING 31286 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 6084748 EUROPE 2 19 MANAGEMENT & GENERAL 2798482 EUROPE 0 0 PROGRAM SERVICES PRODUCT DEVELOPMENT 6265440 EUROPE 0 0 PROGRAM SERVICES INTERNATIONAL DEVELOPMENT 1072713 EUROPE 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 3297906 EUROPE 0 0 PROGRAM SERVICES OTHER 121589 EUROPE 0 0 GRANTMAKING 16672917 MIDDLE EAST AND NORTH AFRICA 0 0 MANAGEMENT & GENERAL 19863 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES PRODUCT DEVELOPMENT 59619 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 75235 MIDDLE EAST AND NORTH AFRICA 0 0 FUNDRAISING 9734 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 48554 NORTH AMERICA 0 0 MANAGEMENT & GENERAL 33677 NORTH AMERICA 0 0 PROGRAM SERVICES PRODUCT DEVELOPMENT 508105 NORTH AMERICA 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 154252 RUSSIA & THE NEWLY INDEPENDENT STATES 1 11 MANAGEMENT & GENERAL 130796 RUSSIA & THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES INTERNATIONAL DEVELOPMENT 169250 RUSSIA & THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 5272 RUSSIA & THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES OTHER 12407 RUSSIA & THE NEWLY INDEPENDENT STATES 0 0 GRANTMAKING 1074197 SOUTH AMERICA 1 2 MANAGEMENT & GENERAL 68187 SOUTH AMERICA 0 0 PROGRAM SERVICES PRODUCT DEVELOPMENT 53634 SOUTH AMERICA 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 332586 SOUTH AMERICA 0 0 GRANTMAKING 436453 SOUTH ASIA 5 68 MANAGEMENT & GENERAL 1649128 SOUTH ASIA 0 0 PROGRAM SERVICES PRODUCT DEVELOPMENT 681210 SOUTH ASIA 0 0 PROGRAM SERVICES INTERNATIONAL DEVELOPMENT 2191355 SOUTH ASIA 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 583036 SOUTH ASIA 0 0 PROGRAM SERVICES OTHER 18082 SOUTH ASIA 0 0 GRANTMAKING 2038854 SUB-SAHARAN AFRICA 19 479 MANAGEMENT & GENERAL 8762172 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES PRODUCT DEVELOPMENT 3429509 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES INTERNATIONAL DEVELOPMENT 30107684 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES PUBLIC HEALTH IMPACT 8937913 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES OTHER 69811 SUB-SAHARAN AFRICA 0 0 FUNDRAISING 1968 SUB-SAHARAN AFRICA 0 0 GRANTMAKING 12971101 6 58 28 579 34 637 6533912 110978725 117512637 EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 300034 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 242857 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 159953 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 130131 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 111295 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 110531 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 104051 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 100208 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 84692 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 76034 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 72134 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 49444 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 49007 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 45084 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 21552 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 20000 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 19818 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 18289 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 9823 CHECK/WIRE EAST ASIA AND PACIFIC INTERNATIONAL DEVELOPMENT 6357 CHECK/WIRE EAST ASIA AND PACIFIC OTHER 5000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 1152759 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 550000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 233775 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 140753 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 85558 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 75000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 61522 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 54695 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 50000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 32466 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 31659 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 20000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 15246 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 15000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 11000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 10000 CHECK/WIRE EAST ASIA AND PACIFIC PRODUCT DEVELOPMENT 9000 CHECK/WIRE EAST ASIA AND PACIFIC PUBLIC HEALTH IMPACT 1823666 CHECK/WIRE EAST ASIA AND PACIFIC PUBLIC HEALTH IMPACT 30000 CHECK/WIRE EUROPE OTHER 280627 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 4105785 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 1206054 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 1110000 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 960344 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 750000 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 475523 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 568601 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 481649 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 296305 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 252639 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 243354 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 236942 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 204101 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 203549 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 200000 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 183600 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 173893 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 151512 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 129000 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 99292 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 88590 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 70000 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 64131 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 43000 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 38753 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 34488 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 33280 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 25358 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 19924 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 12802 CHECK/WIRE EUROPE PRODUCT DEVELOPMENT 12539 CHECK/WIRE EUROPE PUBLIC HEALTH IMPACT 300354 CHECK/WIRE EUROPE PUBLIC HEALTH IMPACT 114412 CHECK/WIRE EUROPE PUBLIC HEALTH IMPACT 59684 CHECK/WIRE EUROPE PUBLIC HEALTH IMPACT 53370 CHECK/WIRE EUROPE PUBLIC HEALTH IMPACT 50000 CHECK/WIRE EUROPE PUBLIC HEALTH IMPACT 33253 CHECK/WIRE EUROPE PUBLIC HEALTH IMPACT 18212 CHECK/WIRE EUROPE INTERNATIONAL DEVELOPMENT 3352920 CHECK/WIRE MIDDLE EAST AND NORTH AFRICA PUBLIC HEALTH IMPACT 39999 CHECK/WIRE MIDDLE EAST AND NORTH AFRICA PUBLIC HEALTH IMPACT 8555 CHECK/WIRE RUSSIA & THE NEWLY INDEPENDENT STATES INTERNATIONAL DEVELOPMENT 126105 CHECK/WIRE RUSSIA & THE NEWLY INDEPENDENT STATES INTERNATIONAL DEVELOPMENT 28505 CHECK/WIRE RUSSIA & THE NEWLY INDEPENDENT STATES PRODUCT DEVELOPMENT 919588 CHECK/WIRE SOUTH AMERICA PRODUCT DEVELOPMENT 136834 CHECK/WIRE SOUTH AMERICA PRODUCT DEVELOPMENT 39177 CHECK/WIRE SOUTH AMERICA PRODUCT DEVELOPMENT 31046 CHECK/WIRE SOUTH AMERICA PRODUCT DEVELOPMENT 22370 CHECK/WIRE SOUTH AMERICA PRODUCT DEVELOPMENT 10000 CHECK/WIRE SOUTH AMERICA PUBLIC HEALTH IMPACT 159298 CHECK/WIRE SOUTH AMERICA PUBLIC HEALTH IMPACT 15126 CHECK/WIRE SOUTH AMERICA PUBLIC HEALTH IMPACT 7298 CHECK/WIRE SOUTH AMERICA PUBLIC HEALTH IMPACT 6304 CHECK/WIRE SOUTH AMERICA PUBLIC HEALTH IMPACT 6000 CHECK/WIRE SOUTH ASIA INTERNATIONAL DEVELOPMENT 604430 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 259447 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 222095 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 211547 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 150000 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 143851 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 130311 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 100000 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 75000 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 20000 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 18019 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 17441 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 13521 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 10000 CHECK/WIRE SOUTH ASIA PRODUCT DEVELOPMENT 10000 CHECK/WIRE SOUTH ASIA PUBLIC HEALTH IMPACT 14710 CHECK/WIRE SOUTH ASIA PUBLIC HEALTH IMPACT 12835 CHECK/WIRE SOUTH ASIA PUBLIC HEALTH IMPACT 9609 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 974571 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 632960 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 205314 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 108717 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 92988 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 82187 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 81887 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 58968 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 58033 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 55084 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 53761 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 52401 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 52047 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 50802 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 50510 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 50375 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 49354 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 47014 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 46182 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 45899 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 45729 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 45420 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 45277 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 45268 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 44662 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 43085 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 43063 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 42936 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 42726 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 42670 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 42661 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 42118 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 42096 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 41602 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 41287 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 41127 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 41030 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 40504 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 39451 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 39375 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 38536 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 37658 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 37492 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 37492 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 37425 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 36825 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 35683 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 35650 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 35627 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 35562 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 34852 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 34263 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 34142 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 33789 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 33195 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 33044 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 32758 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 32332 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 32021 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 32001 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 31381 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 30719 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 30702 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 30600 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 28556 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 28512 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 28396 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 28021 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 27429 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 26497 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 25855 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 25151 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 24299 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 23633 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 23616 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 23030 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 22795 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 22743 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 22631 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 22229 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 21377 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 21040 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 20092 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 19412 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 18269 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 17034 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 15704 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 11282 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 10472 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 5557 CHECK/WIRE SUB-SAHARAN AFRICA INTERNATIONAL DEVELOPMENT 5170 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 19978 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 18934 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 17755 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 15885 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 15872 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 15641 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 15632 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 15048 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 14580 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 14317 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 14104 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 14054 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 13995 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 13737 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 13672 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12940 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12885 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12810 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12655 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12525 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12441 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12339 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 12042 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 11958 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 11857 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 11786 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 11770 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 11623 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 11591 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 11306 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 10897 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 10612 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 10467 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 10391 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9877 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9708 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9570 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9276 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9101 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9037 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9015 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 9011 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 8630 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 8602 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 8456 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 8430 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 8212 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7984 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7900 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7819 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7795 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7720 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7690 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7569 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 7368 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 6400 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 6273 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 6166 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 6126 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 5743 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 5732 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 5730 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 5689 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 5460 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 5388 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 229993 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 207445 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 197642 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 194604 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 168621 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 137526 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 136999 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 114244 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 113937 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 94380 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 91774 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 86770 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 85315 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 78785 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 64370 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 55712 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 53547 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 50000 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 41909 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 41254 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 41068 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 40558 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 34798 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 33041 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 29621 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 26300 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 25000 CHECK/WIRE SUB-SAHARAN AFRICA PUBLIC HEALTH IMPACT 22099 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 10000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 10000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 10000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 10000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 9925 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 9920 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 9000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 9000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 9000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 8000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 6039 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 5500 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 5000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 5000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 5000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 5000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 5000 CHECK/WIRE SUB-SAHARAN AFRICA OTHER 5000 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 667324 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 641489 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 540675 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 405645 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 341897 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 175000 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 169804 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 165650 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 113570 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 83267 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 81287 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 79989 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 78627 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 72429 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 71668 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 66460 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 64561 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 62162 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 56462 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 49988 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 47664 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 45200 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 44502 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 44179 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 42661 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 31603 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 30000 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 27976 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 27018 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 23747 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 23027 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 20136 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 15562 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 15257 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 12356 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 8000 CHECK/WIRE SUB-SAHARAN AFRICA PRODUCT DEVELOPMENT 7924 CHECK/WIRE 255 45 1 0 0 0 0 0 PART I, LINE 2: SUBRECIPIENTS MUST SUBMIT PROGRESS REPORTS THAT ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS OR FOLLOW UP ON ANY AREA OF CONCERN. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET FUTURE BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. 1 AKROS INC - RESEARCH ANALYTICS 3350 LAZERA RANCH ROAD CHEYENNE WY 82007 263668995 N/A 970561 INTERNATIONAL DEVELOPMENT AKROS INC - RESEARCH ANALYTICS 3350 LAZERA RANCH ROAD CHEYENNE WY 82007 263668995 N/A 182472 INTERNATIONAL DEVELOPMENT AKROS INC - RESEARCH ANALYTICS 3350 LAZERA RANCH ROAD CHEYENNE WY 82007 263668995 N/A 11884 INTERNATIONAL DEVELOPMENT BOSTON UNIVERSITY ONE SILBER WAY BOSTON MA 02215 042103547 501(C)(3) 80220 INTERNATIONAL DEVELOPMENT ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) 1140 CONNECTICUT AVENUE NW WASHINGTON DC 20036 954191698 501(C)(3) 3512395 INTERNATIONAL DEVELOPMENT ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) 1140 CONNECTICUT AVENUE NW WASHINGTON DC 20036 954191698 501(C)(3) 203604 INTERNATIONAL DEVELOPMENT FAMILY HEALTH INTERNATIONAL (FHI) 360 PO BOX 13950 2224 E NC HWY 54 DURHAM NC 27713 237413005 501(C)(3) 225780 INTERNATIONAL DEVELOPMENT HARVARD SCHOOL OF PUBLIC HEALTH INTERNATIONAL HEALTH 665 HUNTINGTON AVENUE BOSTON MA 02215 042103580 501(C)(3) 120748 INTERNATIONAL DEVELOPMENT HEALTH ALLIANCE INTERNATIONAL 4534 11TH AVE NE SEATTLE WA 98105 951831116 501(C)(3) 55783 INTERNATIONAL DEVELOPMENT JHPIEGO CORPORATION 1615 THAMES STREET BALTIMORE MD 21231 237424444 501(C)(3) 3538689 INTERNATIONAL DEVELOPMENT MEDICAL CARE DEVELOPMENT INC (MCD) 8401 COLESVILLE ROAD 425 SILVER SPRING MD 20910 016022787 501(C)(3) 1627303 INTERNATIONAL DEVELOPMENT POPULATION SERVICES INTERNATIONAL (PSI) 1120 19TH STREET NW SUITE 600 WASHINGTON DC 20036 560942853 501(C)(3) 213296 INTERNATIONAL DEVELOPMENT SAVE THE CHILDREN 501 KINGS HWY E FAIRFIELD CT 068254861 060726487 501(C)(3) 145728 INTERNATIONAL DEVELOPMENT TULANE UNIVERSITY TULANE SCHOOL OF PUBLIC HEALTH 1440 CANAL ST SUITE 2200 NEW ORLEANS LA 70112 720423889 501(C)(3) 178440 INTERNATIONAL DEVELOPMENT WORLD VISION P O BOX 9716 DEPT W FEDERAL WAY WA 980639716 951922279 501(C)(3) 3440000 INTERNATIONAL DEVELOPMENT AIDS VACCINE ADVOCACY COALITION 423 W 127TH ST FL 4 NEW YORK NY 10027 943240841 501(C)(3) 5000 OTHER POPULATION ACTION INTERNATIONAL 1300 19TH STREET NW WASHINGTON DC 20036 520812075 501(C)(3) 111686 OTHER WOMEN DELIVER 588 BROADWAY SUITE 5033 NEW YORK NY 10012 264462256 501(C)(3) 60000 OTHER ACCELOVANCE INC 2275 RESEARCH BOULEVARD ROCKVILLE MD 20850 200956757 N/A 140614 PRODUCT DEVELOPMENT ADVANCED BIOSCIENCE LABORATORIES INC 9800 MEDICAL CENTER DRIVE BUILDING D ROCKVILLE MD 20850 621242262 N/A 173200 PRODUCT DEVELOPMENT BERKELEY AIR MONITORING GROUP 2124 KITTREDGE STREET 57 BERKELEY CA 94704 263881064 N/A 86580 PRODUCT DEVELOPMENT CASCADE DESIGNS INC 4000 FIRST AVENUE SOUTH SEATTLE WA 98134 910969695 N/A 13437 PRODUCT DEVELOPMENT CASCADE DESIGNS INC 4000 FIRST AVENUE SOUTH SEATTLE WA 98134 910969695 N/A 12331 PRODUCT DEVELOPMENT CDC FOUNDATION 55 PARK PLACE NE SUITE 400 ATLANTA GA 30303 582106707 501(C)(3) 392954 PRODUCT DEVELOPMENT CDC FOUNDATION 55 PARK PLACE NE SUITE 400 ATLANTA GA 30303 582106707 501(C)(3) 30920 PRODUCT DEVELOPMENT CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) US FOOD DRUG ADMINISTRATION 8800 ROCKVILLE PIKE BETHESDA MD 20892 530196965 GOVERNMENT 75000 PRODUCT DEVELOPMENT CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) 1600 CLIFTON ROAD ATLANTA GA 30333 586051157 GOVERNMENT 155102 PRODUCT DEVELOPMENT CONRAD EASTERN VIRGINIA MEDICAL SCHOOL 1911 NORTH FORT MYER DRIVE SUITE 90 ARLINGTON VA 22209 237053028 501(C)(3) 59064 PRODUCT DEVELOPMENT DIGITAL GREEN FOUNDATION 2342 SHATTUCK AVENUE 151 BERKELEY CA 94704 262418959 501(C)(3) 7101 PRODUCT DEVELOPMENT EXPRESSION ANALYSIS INC 4324 S ALSTON AVE 101 DURHAM NC 27713 522340631 N/A 544850 PRODUCT DEVELOPMENT FOOD & DRUG ADMINISTRATION (FDA) 10903 NEW HAMPSHIRE AVENUE SILVER SPRING MD 20993 530196965 GOVERNMENT 629872 PRODUCT DEVELOPMENT FOOD & DRUG ADMINISTRATION (FDA) 10903 NEW HAMPSHIRE AVENUE SILVER SPRING MD 20993 530196965 GOVERNMENT 55000 PRODUCT DEVELOPMENT FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 130545 PRODUCT DEVELOPMENT FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 8016 PRODUCT DEVELOPMENT GEORGE WASHINGTON UNIVERSITY 2175 K STREET NW SUITE 700 WASHINGTON DC 20037 530196584 501(C)(3) 17335 PRODUCT DEVELOPMENT GORDON RESEARCH CONFERENCES 512 LIBERTY LANE WEST KINGSTON RI 02892 260150662 501(C)(3) 20000 PRODUCT DEVELOPMENT INOVIO BIOMEDICAL CORPORATION 450 SENTRY PARKWAY BLUE BELL PA 19422 330969592 N/A 460592 PRODUCT DEVELOPMENT INTERNATIONAL AIDS VACCINE INITIATIVE (IAVI) 125 BROAD STREET 9TH FLOOR NEW YORK NY 10004 133870223 501(C)(3) 63920 PRODUCT DEVELOPMENT JOHN SNOW INC (JSI) 44 FARNSWORTH STREET BOSTON MA 02210 042578580 N/A 335548 PRODUCT DEVELOPMENT JOHN SNOW INC (JSI) 44 FARNSWORTH STREET BOSTON MA 02210 042578580 N/A 59424 PRODUCT DEVELOPMENT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 112491 PRODUCT DEVELOPMENT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 69970 PRODUCT DEVELOPMENT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 59557 PRODUCT DEVELOPMENT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 23252 PRODUCT DEVELOPMENT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 17325 PRODUCT DEVELOPMENT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 10536 PRODUCT DEVELOPMENT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 9569 PRODUCT DEVELOPMENT LOYOLA UNIVERSITY CHICAGO 6339 N SHERIDAN ROAD CHICAGO IL 60660 361408475 501(C)(3) 171035 PRODUCT DEVELOPMENT NAT INS OF ALLERGY & INFECTIOUS DISEASES (NIAID) 6610 ROCKLEDGE DRIVE SUITE 2800 MSC 6606 BETHESDA MD 208926606 520858115 GOVERNMENT 955525 PRODUCT DEVELOPMENT NAT INS OF ALLERGY & INFECTIOUS DISEASES (NIAID) 6610 ROCKLEDGE DRIVE SUITE 2800 MSC 6606 BETHESDA MD 208926606 520858115 GOVERNMENT 630611 PRODUCT DEVELOPMENT NAT INS OF ALLERGY & INFECTIOUS DISEASES (NIAID) 6610 ROCKLEDGE DRIVE SUITE 2800 MSC 6606 BETHESDA MD 208926606 520858115 GOVERNMENT 192414 PRODUCT DEVELOPMENT NEW YORK UNIVERSITY 105 E 17TH ST 4TH FLOOR NEW YORK NY 100039530 135562308 501(C)(3) 138302 PRODUCT DEVELOPMENT NORTIS INC C4C NEW VENTURE FACILITY 4000 MASON RD ROOM 304 FLUKE HALL PO BOX 35214 SEATTLE WA 98195 680649212 N/A 418004 PRODUCT DEVELOPMENT NORTIS INC C4C NEW VENTURE FACILITY 4000 MASON RD ROOM 304 FLUKE HALL PO BOX 35214 SEATTLE WA 98195 680649212 N/A 15003 PRODUCT DEVELOPMENT PATH DRUG SOLUTIONS 2201 WESTLAKE AVE SUITE 200 SEATTLE WA 98121 943384500 501(C)(3) 535489 GENERAL SUPPORT PATH VACINNE SOLUTIONS 2201 WESTLAKE AVE SUITE 200 SEATTLE WA 98121 830431851 501(C)(3) 424773 GENERAL SUPPORT PAN AMERICAN HEALTH ORGANIZATION (PAHO) 525 TWENTY-THIRD STREET NW WASHINGTON DC 20037 237072046 501(C)(3) 50000 PRODUCT DEVELOPMENT PHARMAJET INC 400 CORPORATE CIRCLE GOLDEN CO 80401 203058403 N/A 200000 PRODUCT DEVELOPMENT POPULATION SERVICES INTERNATIONAL (PSI) 1120 19TH STREET NW SUITE 600 WASHINGTON DC 20036 560942853 501(C)(3) 39790 PRODUCT DEVELOPMENT POPULATION SERVICES INTERNATIONAL (PSI) 1120 19TH STREET NW SUITE 600 WASHINGTON DC 20036 560942853 501(C)(3) 18699 PRODUCT DEVELOPMENT PRICE CONSULTING LLC 2617 BOYER AVE E SEATTLE WA 98121 462513741 N/A 6090 PRODUCT DEVELOPMENT PUBLIC HEALTH INSTITUTE 555 12TH STREET 10TH FLOOR OAKLAND CA 946074046 941646278 501(C)(3) 427336 PRODUCT DEVELOPMENT RAINIER CLINICAL RESEARCH CENTER INC 723 SW 10TH STREET STE 100 RENTON WA 98057 911565985 N/A 18155 PRODUCT DEVELOPMENT SABIN VACCINE INSTITUTE 2000 PENNSYLVANIA AVENUE SUITE 7100 7100 WASHINGTON DC 20036 061389829 501(C)(3) 100000 PRODUCT DEVELOPMENT SANARIA INC 9800 MEDICAL CENTER DR A209 ROCKVILLE MD 20850 562354362 N/A 1400000 PRODUCT DEVELOPMENT SANARIA INC 9800 MEDICAL CENTER DR A209 ROCKVILLE MD 20850 562354362 N/A 295000 PRODUCT DEVELOPMENT SANARIA INC 9800 MEDICAL CENTER DR A209 ROCKVILLE MD 20850 562354362 N/A 160000 PRODUCT DEVELOPMENT SAVE THE CHILDREN 501 KINGS HWY E FAIRFIELD CT 068254861 060726487 501(C)(3) 27000 PRODUCT DEVELOPMENT SEATTLE BIOMEDICAL RESEARCH INSTITUTE 307 WESTLAKE AVE N SUITE 500 SEATTLE WA 981095219 910961784 501(C)(3) 64236 PRODUCT DEVELOPMENT SEATTLE BIOMEDICAL RESEARCH INSTITUTE (SBRI) 307 WESTLAKE AVE N SUITE 500 SEATTLE WA 981095219 910961784 501(C)(3) 55007 PRODUCT DEVELOPMENT SEATTLE BIOMEDICAL RESEARCH INSTITUTE (SBRI) 307 WESTLAKE AVE N SUITE 500 SEATTLE WA 981095219 910961784 501(C)(3) 145000 PRODUCT DEVELOPMENT SYMBIENT PRODUCT DEVELOPMENT 1061 LA MIRADA CT VISTA CA 981095219 200857602 N/A 14064 PRODUCT DEVELOPMENT THE POPULATION COUNCIL ONE DAG HAMMARSKJOLD PLAZA 9TH FLOOR NEW YORK NY 10017 520595110 501(C)(3) 1024439 PRODUCT DEVELOPMENT US NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVE SILVER SPRING MD 209107500 470100048 GOVERNMENT 400000 PRODUCT DEVELOPMENT US NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVE SILVER SPRING MD 209107500 470100048 GOVERNMENT 300000 PRODUCT DEVELOPMENT US NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVE SILVER SPRING MD 209107500 470100048 GOVERNMENT 180863 PRODUCT DEVELOPMENT UNIVERSITY OF FLORIDA 219 GRINTER HALL PO BOX 115500 GAINESVILLE FL 326115500 596002052 501(C)(3) 60000 PRODUCT DEVELOPMENT UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC 2385 IRVING HILL ROAD LAWRENCE KS 66045 480680117 501(C)(3) 110000 PRODUCT DEVELOPMENT UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC 2385 IRVING HILL ROAD LAWRENCE KS 66045 480680117 501(C)(3) 6000 PRODUCT DEVELOPMENT UNIVERSITY OF MARYLAND BALTIMORE PO BOX 41428 BALTIMORE MD 212036428 526002033 GOVERNMENT 600000 PRODUCT DEVELOPMENT UNIVERSITY OF MIAMI 1320 SOUTH DIXIE HIGHWAY GABLES ONE TOWER SUITE 650 CORAL GABLES FL 33146 590624458 501(C)(3) 12496 PRODUCT DEVELOPMENT UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 720 MARTIN LUTHER KING JR BLVD SUITE CHAPEL HILL NC 275993368 566001393 501(C)(3) 46566 PRODUCT DEVELOPMENT UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 720 MARTIN LUTHER KING JR BLVD SUITE CHAPEL HILL NC 275993368 566001393 501(C)(3) 12812 PRODUCT DEVELOPMENT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE BOX 359472 SEATTLE WA 98195 916001537 501(C)(3) 138384 PRODUCT DEVELOPMENT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE BOX 359472 SEATTLE WA 98195 916001537 501(C)(3) 46303 PRODUCT DEVELOPMENT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE BOX 359472 SEATTLE WA 98195 916001537 501(C)(3) 17414 PRODUCT DEVELOPMENT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE BOX 359472 SEATTLE WA 98195 916001537 501(C)(3) 17846 PRODUCT DEVELOPMENT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE BOX 359472 SEATTLE WA 98195 916001537 501(C)(3) 5996 PRODUCT DEVELOPMENT VAXESS TECHNOLOGIES INC 125 WESTERN AVENUE ALLSTON MA 02134 460612554 N/A 8071 PRODUCT DEVELOPMENT VENTURE STRATEGIES INNOVATIONS 19200 VON KARMAN AVENUE SUITE 400 IRVINE CA 92612 262813021 501(C)(3) 90084 PRODUCT DEVELOPMENT VILLAGEREACH 601 NORTH 34TH STREET SEATTLE WA 98103 912082484 501(C)(3) 182739 PRODUCT DEVELOPMENT VILLAGEREACH 601 NORTH 34TH STREET SEATTLE WA 98103 912082484 501(C)(3) 55000 PRODUCT DEVELOPMENT VILLAGEREACH 601 NORTH 34TH STREET SEATTLE WA 98103 912082484 501(C)(3) 16000 PRODUCT DEVELOPMENT WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT DRIVE SILVER SPRING MD 20910 520664528 GOVERNMENT 902250 PRODUCT DEVELOPMENT WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT DRIVE SILVER SPRING MD 20910 520664528 GOVERNMENT 449966 PRODUCT DEVELOPMENT WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT DRIVE SILVER SPRING MD 20910 520664528 GOVERNMENT 198508 PRODUCT DEVELOPMENT WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT DRIVE SILVER SPRING MD 20910 520664528 GOVERNMENT 172063 PRODUCT DEVELOPMENT WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT DRIVE SILVER SPRING MD 20910 520664528 GOVERNMENT 53739 PRODUCT DEVELOPMENT YALE UNIVERSITY 310 CEDAR STREET NEW HAVEN CT 06510 060646973 501(C)(3) 472421 PRODUCT DEVELOPMENT DALBERG CONSULTING US LLC 99 MADISON AVENUE 17TH FLOOR NEW YORK NY 10016 261546220 N/A 181081 PUBLIC HEALTH IMPACT EMORY UNIVERSITY 1599 CLIFTON RD NE 4TH FLOOR MAILSTOP 1499/001/1BH ATLANTA GA 303224250 580566256 501(C)(3) 807288 PUBLIC HEALTH IMPACT FAMILY HEALTH INTERNATIONAL (FHI) 360 PO BOX 13950 2224 E NC HWY 54 DURHAM NC 27713 237413005 501(C)(3) 158739 PUBLIC HEALTH IMPACT FAMILY HEALTH INTERNATIONAL (FHI) 360 PO BOX 13950 2224 E NC HWY 54 DURHAM NC 27713 237413005 501(C)(3) 101460 PUBLIC HEALTH IMPACT FINANCING FOR DEVELOPMENT 1800 MASSACHUSETTS AVENUE SUITE 400 400 WASHINGTON DC 20036 680683026 501(C)(3) 370000 PUBLIC HEALTH IMPACT FINANCING FOR DEVELOPMENT 1800 MASSACHUSETTS AVENUE SUITE 400 400 WASHINGTON DC 20036 680683026 501(C)(3) 91565 PUBLIC HEALTH IMPACT GREENEWORKS GLOBAL LLC 3733 WARREN STREET NW WASHINGTON DC 20016 800672849 N/A 25000 PUBLIC HEALTH IMPACT JOHN SNOW INC (JSI) 44 FARNSWORTH STREET BOSTON MA 02210 042578580 N/A 5000 PUBLIC HEALTH IMPACT JOHNS HOPKINS UNIVERSITY (JHU) 3400 N CHARLES ST BALTIMORE MD 21218 131687001 501(C)(3) 121783 PUBLIC HEALTH IMPACT KANSAS STATE UNIVERSITY COLLEGE OF VETERINARY MEDICINE MANHATTAN KS 665065601 480771751 501(C)(3) 12300 PUBLIC HEALTH IMPACT KYBELE INC 3524 YADKINVILLE ROAD 124 WINSTON SALEM NC 27106 900759003 501(C)(3) 132122 PUBLIC HEALTH IMPACT POPULATION ACTION INTERNATIONAL 1300 19TH STREET NW WASHINGTON DC 20036 520812075 501(C)(3) 36518 PUBLIC HEALTH IMPACT THE POPULATION COUNCIL ONE DAG HAMMARSKJOLD PLAZA 9TH FLOOR NEW YORK NY 10017 520595110 501(C)(3) 771119 PUBLIC HEALTH IMPACT US PHARMACOPEIAL CONVENTION USP HEADQUARTERS 12601 TWIN BROOK PARKWAY ROCKVILLE MD 208521790 131656692 501(C)(3) 25000 PUBLIC HEALTH IMPACT WORLD VISION INC P O BOX 9716 DEPT W FEDERAL WAY WA 980639716 951922279 501(C)(3) 19472 PUBLIC HEALTH IMPACT PROFECTUS BIOSCIENCES INC 6411 BECKLEY ST BALTIMORE MD 21224 020579416 N/A -29030 PRODUCT DEVELOPMENT SEATTLE BIOMEDICAL RESEARCH INSTITUTE 307 WESTLAKE AVE N 500 SEATTLE WA 98109 910961784 501(C)(3) -30339 PRODUCT DEVELOPMENT 51 18 PART I, LINE 2: SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. X X 1 1 X X X X 1 0 0 0 0 0 0 1 0 STEVEN B DAVIS PRESIDENT AND CEO 420801 0 59938 0 500 0 30600 0 11028 0 522867 0 0 0 ERIC G WALKER VP, CORPORATE SVC. (UNTIL 10/2/2013) 351054 0 0 0 1000 0 25448 0 9163 0 386665 0 0 0 MICHAEL B KOLLINS COO (BEGAN 5/31/2013) 138498 0 0 0 1769 0 6417 0 6433 0 153117 0 0 0 DAVID C KASLOW VP, PRODUCT DEV. (BEGAN 10/1/2013) 322388 0 0 0 75 0 28491 0 11028 0 361982 0 0 0 AYORINDE ARNOLD AJAYI VP, INTERNATIONAL DEVELOPMENT 256904 0 0 0 0 0 28482 0 6256 0 291642 0 0 0 SARAH C TEMPLE VP, EXTERNAL RELATIONS 225325 0 0 0 770 0 27031 0 8880 0 262006 0 0 0 DAN LASTER GENERAL COUNSEL 224390 0 0 0 770 0 24497 0 11001 0 260658 0 0 0 JACQUELINE D SHERRIS VP, PUBLIC HEALTH IMPACT 208637 0 0 0 244 0 24564 0 2876 0 236321 0 0 0 KATHRYN A O'DRISCOLL CHIEF HUMAN RESOURCES OFFICER 206023 0 0 0 770 0 24696 0 10934 0 242423 0 0 0 AMIE E BATSON CHIEF STRATEGY OFF. (BEGAN 4/8/13) 178128 0 15000 0 0 0 9625 0 954 0 203707 0 0 0 JOHN W BOSLEGO DIRECTOR, VACCINE DEV. GLOBAL PROG. 319488 0 0 0 0 0 30600 0 9390 0 359478 0 0 0 PAWANA WIENRAWEE DIRECTOR, THAILAND PROGRAMS 127093 0 0 0 157261 0 15251 0 8753 0 308358 0 0 0 PONNI SUBBIAH DIRECTOR, DRUG DEVELOPMENT 276446 0 0 0 770 0 21547 0 9787 0 308550 0 0 0 RIKKA E TRANGSRUD COUNTRY PROGRAM LEADER, KENYA 169524 0 0 0 106132 0 19210 0 9773 0 304639 0 0 0 TRAD M HATTON CHIEF OF PARTY, INTEGRATED HIV/AIDS 167929 0 0 0 97468 0 14031 0 10065 0 289493 0 0 0 CARLOS CLINTON CAMPBELL DIRECTOR, MALARIA CONTROL PROGRAM 249335 0 0 0 5339 0 25332 0 2531 0 282537 0 0 0 ANURAG PRABHAKAR MAIRAL DIRECTOR, TECHNOLOGY SOLUTIONS 214170 0 25000 0 15280 0 16150 0 8892 0 279492 0 0 0 ASHLEY BIRKETT DIRECTOR, RESEARCH AND DEVELOPMENT 239169 0 0 0 6096 0 26189 0 11026 0 282480 0 0 0 RAMONA ANNE BYRKIT COUNTRY PROGRAM LEADER, VIETNAM 160685 0 0 0 82164 0 19220 0 10202 0 272271 0 0 0 KATHLEEN M NEUZIL GLOBAL PROGRAM LEADER, VAD 234320 0 0 0 0 0 24962 0 9958 0 269240 0 0 0 CATHARINE HOWARD TAYLOR GLOBAL PROGRAM LEADER, MCHN 210119 0 0 0 0 0 25214 0 7689 0 243022 0 0 0 JANE E HUTCHINGS DIRECTOR, REPRODUCTIVE HEALTH 198328 0 0 0 0 0 23115 0 10881 0 232324 0 0 0 RACHEL WILSON SENIOR DIRECTOR, POLICY & ADVOCACY 190167 0 0 0 75 0 22812 0 9345 0 222399 0 0 0 JOHN SKIBIAK DIRECTOR, RHSC 190662 0 0 0 76887 0 22824 0 10279 0 300652 0 0 0 JEAN A NTUMBA BIDUAYA FIN. & ADMIN. SPECIALIST, HIV & TB 81509 0 0 0 168173 0 8933 0 9967 0 268582 0 0 0 DUNCAN OWENS EARLE PROG. DIR., MALARIA CONTROL & EVAL. 210890 0 0 0 32700 0 25307 0 5544 0 274441 0 0 0 BONIFACE MUTOMBO WA MUTOMBO SENIOR PROGRAM OFFICER 133860 0 0 0 106428 0 16063 0 8785 0 265136 0 0 0 GEORGE A ROBERTSON SENIOR TECHNICAL ADVISOR 228411 0 0 0 0 0 27409 0 10944 0 266764 0 0 0 PART I, LINE 1A HOUSING ALLOWANCE & TAX INDEMNIFICATION ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITION. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT. PART I, LINE 4A SEVERANCE WAS PAID TO BONIFACE MUTOMBO WA MUTOMBO ($42,180) AND PAWANA WIENRAWEE ($156,115). PART I, LINE 7 BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II). X 17 81103 FMV X SUPPLIES 5 24759 COST OR SALES PRICE X EQUIPMENT 1 1245 COST OR SALES PRICE X SOFTWARE 1 379 COST OR SALES PRICE 0 0 1 0 PART I, COLUMN (B): THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE FINAL 990 WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CFO SIGNED THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS, PATH MANAGEMENT, AND ALL STAFF ABOVE A DESIGNATED LEVEL IN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD'S COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARY AND BENEFITS FOR KEY EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE CEO ON COMPENSATION DECISIONS FOR KEY POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT AND CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR AT THE MAY BOARD MEETING. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO AND VICE PRESIDENTS). THE LAST MAJOR REVIEW WAS COMPLETED IN 2014, WHEN PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND PROGRAM/DEPARTMENT LEADERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE COMPENSATION PACKAGES FOR THE VICE PRESIDENTS, WITH RATIFICATION BY THE BOARD. THE BOARD ALSO APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S COMPENSATION. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFIT PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD REVIEWED MERCER'S FINDINGS AND APPROVED THE TOTAL PACKAGE FOR THIS POSITION. FORM 990, PART VI, SECTION C, LINE 19 PATH MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. PATH VACCINE SOLUTIONS 2201 WESTLAKE AVENUE SEATTLE WA 98109 830431851 ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN WA 501(C)(3) LINE 11A PATH 1 ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH 25 BUILDING B0 SHOTA RUSTAVELI STR KYIV UP REDUCE THE TB BURDEN IN UKRAINE UP N/A N/A PATH 1 PATH DRUG SOLUTIONS 280 UTAH AVENUE SUITE 250 SAN FRANCISCO CA 94080 943384500 DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES CA 501(C)(3) LINE 11A PATH 1 FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND 207 ROUTE DE FERNEY 1218 LE GRAND-S GENEVA SZ EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH SZ N/A N/A PATH 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PATH VACCINE SOLUTIONS C 12702315 FMV PATH VACCINE SOLUTIONS B 424773 FMV ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH C 423280 FMV ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH B 919588 FMV PATH DRUG SOLUTIONS C 4022391 FMV PATH DRUG SOLUTIONS B 535489 FMV FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND C 1325097 FMV FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND B 3352920 FMV